Merkliste 
 1 Ergebnisse 
 
1

Phase 1 study of the MDM2 inhibitor AMG 232 in patients wit..:

Gluck, WL ; Gounder, MM ; Frank, R...
Gluck , WL , Gounder , MM , Frank , R , Eskens , F , Blay , JY , Cassier , PA , Soria , JC , Chawla , S , de Weger , V , Wagner , AJ , Siegel , D , Vos , F , Rasmussen , E & Henary , HA 2020 , ' Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma ' , Investigational New Drugs , vol. 38 , no. 3 , pp. 831-843 . https://doi.org/10.1007/s10637-019-00840-1.  , 2020